 |
|
World Experts Unite in Urgent Effort to Fight Deadly Disease
May 11, 2004* Up to One Million Child Deaths are Preventable *
* New Evidence Shows HIV-Infected Children & Infants are Particularly Vulnerable *
Leaders in the fight against disease today emphasized the importance of preventing unnecessary child deaths from Streptococcus pneumoniae - a disease currently responsible for killing between 800,000 and one million children every year, mostly in developing countries.
The reaffirmed consensus on the need for new interventions to fight the disease came on the eve of the fourth International Symposium on Pneumococci and Pneumococcal Diseases (ISPPD-4) in Helsinki. The 2004 symposium is being organized by the National Public Health Institute of Finland and attended by 600 experts from around the world. The week-long symposium will review and discuss the consequences of Streptococcus pneumoniae -- A common, serious, yet preventable disease.
Dr. Tore Godal, Executive Secretary of the Global Alliance for Vaccines & Immunization (GAVI), Dr. Hanna Nohynek, member of the local ISPPD-4 Scientific Organizing Team, and Dr. Orin Levine, Executive Director of PneumoADIP, issued this statement: "The need to assure access to safe, effective and affordable pneumococcal vaccines for children in the world's poorest countries has never been greater. However, the timely introduction and use of these vaccines in developing countries will require a coordinated effort by leading public health institutions and partnership with vaccine manufacturers to ensure a sustainable, affordable supply of vaccine for developing countries".
The Streptococcus pneumoniae bacterium causes a variety of diseases, such as pneumonia, meningitis and ear infections. "Acute respiratory infections, especially pneumonia, are the leading infectious cause of mortality world wide", stated Dr. Thomas Cherian, of the World Health Organization. "The increasing incidence of HIV makes the problem even more urgent as HIV-infected children and infants have a 20-40 fold increased risk of contracting pneumococcal disease".
New vaccines to prevent deadly pneumococcal infections are now available and widely used in rich countries in North America and Europe. As Dr. Orin Levine, Executive Director of GAVI's PneumoADIP explained, "These vaccines are both safe and highly effective. The routine use of these vaccines in developing countries could substantially reduce infant and child mortality from pneumonia and other serious infections".
"Importantly, it is our collective belief that routine vaccination against pneumococcal disease in developing countries could contribute to achieving the United Nations' ambitious goal of reducing child mortality by two-thirds by 2015", commented Dr. Hanna Nohynek member of the local scientific organizing team of ISPPD-4.
Over the past four years GAVI's and the Vaccine Funds efforts will have contributed to save over 500 000 lives of children -- equivalent to saving the entire population of Helsinki -- and eight million children now have access to immunization for the first time. "GAVI's future ambition is to save the lives of another one million children between 2004 and 2006 by providing the poorest countries with new vaccines and funding to strengthen infrastructure so that millions more children will be full protected", explained Dr. Tore Godal, Executive Secretary, GAVI.
GAVI recently selected and awarded a grant to the Department of International Health at Johns Hopkins Bloomberg School of Public Health to serve as the host for its Pneumococcal Accelerated Development and Introduction Plan (PneumoADIP) team.
Kansanterveyslaitos - National Public Health Institute (KTL)
Dr. Tore Godal, Executive Secretary of the Global Alliance for Vaccines & Immunization (GAVI), Dr. Hanna Nohynek, member of the local ISPPD-4 Scientific Organizing Team, and Dr. Orin Levine, Executive Director of PneumoADIP, issued this statement: "The need to assure access to safe, effective and affordable pneumococcal vaccines for children in the world's poorest countries has never been greater. However, the timely introduction and use of these vaccines in developing countries will require a coordinated effort by leading public health institutions and partnership with vaccine manufacturers to ensure a sustainable, affordable supply of vaccine for developing countries".
The Streptococcus pneumoniae bacterium causes a variety of diseases, such as pneumonia, meningitis and ear infections. "Acute respiratory infections, especially pneumonia, are the leading infectious cause of mortality world wide", stated Dr. Thomas Cherian, of the World Health Organization. "The increasing incidence of HIV makes the problem even more urgent as HIV-infected children and infants have a 20-40 fold increased risk of contracting pneumococcal disease".
New vaccines to prevent deadly pneumococcal infections are now available and widely used in rich countries in North America and Europe. As Dr. Orin Levine, Executive Director of GAVI's PneumoADIP explained, "These vaccines are both safe and highly effective. The routine use of these vaccines in developing countries could substantially reduce infant and child mortality from pneumonia and other serious infections".
"Importantly, it is our collective belief that routine vaccination against pneumococcal disease in developing countries could contribute to achieving the United Nations' ambitious goal of reducing child mortality by two-thirds by 2015", commented Dr. Hanna Nohynek member of the local scientific organizing team of ISPPD-4.
Over the past four years GAVI's and the Vaccine Funds efforts will have contributed to save over 500 000 lives of children -- equivalent to saving the entire population of Helsinki -- and eight million children now have access to immunization for the first time. "GAVI's future ambition is to save the lives of another one million children between 2004 and 2006 by providing the poorest countries with new vaccines and funding to strengthen infrastructure so that millions more children will be full protected", explained Dr. Tore Godal, Executive Secretary, GAVI.
GAVI recently selected and awarded a grant to the Department of International Health at Johns Hopkins Bloomberg School of Public Health to serve as the host for its Pneumococcal Accelerated Development and Introduction Plan (PneumoADIP) team.
Kansanterveyslaitos - National Public Health Institute (KTL)
Pneumonia Current Events and Pneumonia News RSSPrioritizing low-cost, simple health measures would save 2.5 million child lives a year
Almost a third of the children under age five who die each year could be saved if governments rebalance health spending to ensure low-cost, simple interventions such as safe water and hygiene, bed nets and basic maternal and newborn care, leading aid agency World Vision said today. Currently, 8.8 million children a year die before age five, most of preventable causes.
Fewer emergency patients seen within recommended time frame
One in four emergency department patients in 2006 waited longer to be evaluated by a clinician than recommended at triage, an increase from one in five in 1997.
Possible help in fight against muscle-wasting disease
A compound already used to treat pneumonia could become a new therapy for an inherited muscular wasting disease, according to researchers at the University of Oregon and the University of Rochester School of Medicine and Dentistry in New York.
Henry Ford Hospital study: A MRSA strain linked to high death rates
A strain of MRSA that causes bloodstream infections is five times more lethal than other strains and has shown to have some resistance to the potent antibiotic drug vancomycin used to treat MRSA, according to a Henry Ford Hospital study.
Commentary warns of unexpected consequences of proton pump inhibitor use in reflux disease
Despite being highly effective and beneficial for many patients, unexpected consequences are emerging in patients who are prescribed proton pump inhibitors (PPIs) for reflux diseases.
Scientists discover influenza's Achilles heel: Antioxidants
As the nation copes with a shortage of vaccines for H1N1 influenza, a team of Alabama researchers have raised hopes that they have found an Achilles' heel for all strains of the flu-antioxidants.
Lessons from flu seasons past
Pregnant women who catch the flu are at serious risk for flu-related complications, including death, and that risk far outweighs the risk of possible side effects from injectable vaccines containing killed virus, according to an extensive review of published research and data from previous flu seasons.
Older Patients with Dementia at Increased Risk for Flu Mortality
An epidemiological study on pneumonia and influenza (P&I) in adults age 65 and over reports that patients with dementia are diagnosed with flu less frequently, have shorter hospital stays, and have a fifty percent higher rate of death than those without dementia.
OMRF scientists discover promising new path for treating traumas
A discovery by scientists at the Oklahoma Medical Research Foundation could help save lives threatened by traumatic injuries like those sustained in car crashes or on the battlefield. The work also holds potential for treating severe infectious diseases and diabetes.
Scientists create NICE solution to pneumonia vaccine testing problems
Medical clinics the world over could benefit from new software* created at the National Institute of Standards and Technology (NIST), where a team of scientists has found a way to improve the efficiency of a pneumonia vaccine testing method developed at the University of Alabama at Birmingham (UAB).
More Pneumonia Current Events and Pneumonia News Articles
 |
GIANT Microbes - Pneumonia (Streptococcus pneumonia) Plush by Giant Microbes Pneumonia can take your breath away. |
 |
Diagnosis and Management of Pneumonia and Other Respiratory Infections by Alan Fein (Author), Ronald Grossman (Author) Treatment of community-acquired pneumonia and hospital-acquired pneumonia, when to hospitalize a patient, methods of identifying low-risk CAP patients, switch and step-down therapy, approach to nonresloving pneumonia, management of parapneumonic effusions, empyema, and chronic bronchitis are discussed. The various antimicrobial agents are reviewed in deatil with suggested treatment regimens. |
 |
Pneumonia by Whiskeytown In their brief, volatile tenure as a working band--which spawned just two proper albums, Faithless Street (1995) and Strangers Almanac (1997)--Whiskeytown never quite fulfilled their considerable promise. But prior to their ultimate split, the band made a record that was buried for nearly three years by industry snafus. Pneumonia was well worth the wait. The band's final lineup (singer and songwriter Ryan Adams, violinist Caitlin Cary, and guitarist Mike Daly) is augmented by special guests such as Tommy Stinson of the Replacements and James Iha of Smashing Pumpkins. Sure, Adams doesn't quite grasp what he's reaching for on the Latin-tinged "Paper Moon," and "Sit & Listen to the Rain" is about as exciting as its title suggests. But "Jacksonville Skyline," a hometown ode that's sweetly... |
 |
Community Acquired Pneumonia Guidelines Pocketcard : Infecti by International Guidelines Cntr The Community-Acquired Pneumonia GUIDELINES Pocketcard is endorsed by the Infectious Diseases Society of America (IDSA). This practical quick-reference tool contains screening, diagnostic, treatment algorithm, drug therapy, dosing information, patient monitoring and counseling points. |
 |
Rockin' Pneumonia And The Boogie Woogie Flu Johnny Rivers (Primary Contributor) |
 |
Community-Acquired Pneumonia: Strategies for Management by Antoni Torres (Editor), Rosario Menendez (Editor) Community-Acquired Pneumonia (CAP) refers to pneumonia acquired outside of hospitals or extended-care facilities, and is distinct from Nosocomial or hospital-acquired pneumonia, which is a separate disease entity. It is one of the most common respiratory infections and presents one of the major health problems today, with an incidence that ranges from eight to fifty cases per thousand individuals each year. Mortality is still very high and yet the risk factors are very well known. Many of these are related to antibiotic treatment; delay in administration, inadequacy of empiric antibiotics and lack of adherence to guidelines for treatment are all clearly associated with poor treatment outcomes.
Following a description of the epidemiology and microbial etiology of... |
 |
Preventing Flu and Pneumonia Part of the award winning public television series Healthy Body/Healthy Mind. Nearly everyone has heard of "flu season." It's a time of year when forms of the influenza virus are more likely to infect people. Flu and another lung disease, Pneumonia, can be debilitating and deadly. According to the American Lung Association, flu and pneumonia together are ranked as the 7th leading cause of death in the United States. But there are steps people can take to prepare and try to prevent these conditions. This program will outline the basics about flu and pneumonia and offer physician recommendations on the best ways to prevent these diseases. This product is manufactured on demand using DVD-R recordable media. Amazon.com's standard return policy will apply. |
 |
Pneumonia Mini Plush in Petri Dish by Giant Microbes by Giantmicrobes Lots of strange bedfellows check into the infirmary. Pull back the curtain and see who's been admitted. Pneumonia can take your breath away. Includes: Petri Dish and (3 mini Pneumonias) |
 |
Drug Resistant Pneumonia Directed By: Information Television Network |
 |
Alfred Publishing 00-24887 Rockin' Pneumonia and the Boogie Woogie Flu by Alfred Publishing Here's a fun tune! This classic song is now playable by any band thanks to this great new arrangement by Jerry Burns. Solid writing! (1:14)Contributors: Arr. Jerry BurnsSeries: Very Easy Pops for Marching BandLevel: 1.5 (Very Easy)Instrument: Marching Band Format: Conductor Score & PartsCategory: Marching Band |
| © 2009 BrightSurf.com |